Treating Paroxysmal Nocturnal Haemoglobinuria Patients With rVA576
Clinical trial NCT03588026 · COMPLETED
Trial details
- NCT number
- NCT03588026
- Sponsor
- AKARI Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2020-09-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.